Open Access. Powered by Scholars. Published by Universities.®

Life Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 2 of 2

Full-Text Articles in Life Sciences

Discovery Of A Novel Ccr5 Antagonist As An Effective Therapeutic Agent For Prostate Cancer, Tasrif Ahmed Jul 2010

Discovery Of A Novel Ccr5 Antagonist As An Effective Therapeutic Agent For Prostate Cancer, Tasrif Ahmed

Theses and Dissertations

Previously, the CCR5 receptor was found to be a good target for treating prostate cancer (PCa). Dr. Yan Zhang’s laboratory designed several CCR5 antagonists, which were screened for their inhibitory effect on the growth and invasion of the M12, DU145 and PC-3 PCa cell lines. Primary in vitro screening showed one compound (Drug 17) significantly inhibited the proliferation of PCa cells at 1μM concentration, with a half-maximal inhibitory concentration of 237.68 nM. Further in vitro assays including a proliferation, cytotoxicity and invasion assay confirmed the inhibitory effect of drug 17. The physiological effect of drug 17 was tested by the …


Cannabinoid-Mediated Inhibition Of Recurrent Excitatory Circuitry In The Dentate Gyrus In A Mouse Model Of Temporal Lobe Epilepsy, Muthu D. Bhaskaran, Bret N. Smith May 2010

Cannabinoid-Mediated Inhibition Of Recurrent Excitatory Circuitry In The Dentate Gyrus In A Mouse Model Of Temporal Lobe Epilepsy, Muthu D. Bhaskaran, Bret N. Smith

Physiology Faculty Publications

Temporal lobe epilepsy (TLE) is a neurological condition associated with neuron loss, axon sprouting, and hippocampal sclerosis, which results in modified synaptic circuitry. Cannabinoids appear to be anti-convulsive in patients and animal models of TLE, but the mechanisms of this effect are not known. A pilocarpine-induced status epilepticus mouse model of TLE was used to study the effect of cannabinoid agonists on recurrent excitatory circuits of the dentate gyrus using electrophysiological recordings in hippocampal slices isolated from control mice and mice with TLE. Cannabinoid agonists WIN 55,212-2, anandamide (AEA), or 2-arachydonoylglycerol (2-AG) reduced the frequency of spontaneous and tetrodotoxin-resistant excitatory …